版本:
中国

BRIEF-Supernus receives final FDA approval for trokendi XR

April 5 Supernus Pharmaceuticals Inc:

* Supernus receives final FDA approval for trokendi XR for migraine prophylaxis in adults and adolescents

* Supernus Pharmaceuticals Inc - FDA granted final approval to co's supplemental new drug applications requesting label expansion for trokendi XR Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐